• Products
    • VitaSmart™ Hypothermic Oxygenated Perfusion System
    • Belzer UW® Cold Storage Solution
    • Belzer MPS® UW Machine Perfusion Solution
    • EasiSlush® Sodium Chloride Solution
    • Cannulas for Organ Perfusion
    • International Availability
  • About
    • About Bridge to Life Ltd.
    • Company Leadership
    • News & Press Releases
    • Events
    • Scientific Advisory Board
    • Bridge to HOPE
    • Webinars
  • Clinical Resource Library
  • Contact & Support
    • Contact Us
    • Customer Feedback Form
    • Coordinated Vulnerability Disclosure Process
Trusted Solutions. Advanced Technology. Uncompromising Quality.
  • Products
    • VitaSmart™ Hypothermic Oxygenated Perfusion System
    • Belzer UW® Cold Storage Solution
    • Belzer MPS® UW Machine Perfusion Solution
    • EasiSlush® Sodium Chloride Solution
    • Cannulas for Organ Perfusion
    • International Availability
  • About
    • About Bridge to Life Ltd.
    • Company Leadership
    • News & Press Releases
    • Events
    • Scientific Advisory Board
    • Bridge to HOPE
    • Webinars
  • Clinical Resource Library
  • Contact & Support
    • Contact Us
    • Customer Feedback Form
    • Coordinated Vulnerability Disclosure Process

Hypothermic Oxygenated Perfusion

Hypothermic Oxygenated Perfusion
Pushing the Limit for Marginal Grafts in the Era of Machine Perfusion: A Tale of HOPE From a Leading Italian Institution

Pushing the Limit for Marginal Grafts in the Era of Machine Perfusion: A Tale of HOPE From a Leading Italian Institution

Read More
Impact of HOPE on Very Old DCD (>70 Years) Livers: Insights From A Belgian Bi-centeric Experience

Impact of HOPE on Very Old DCD (>70 Years) Livers: Insights From A Belgian Bi-centeric Experience

This bi-centric Belgian study evaluated the impact of end-ischemic HOPE (Hypothermic Oxygenated Perfusion) on very old DCD liver grafts (?70 years old). Compared with static cold storage, HOPE [...]

Read More

Beneficial Effects of End?Ischemic Oxygenated Machine Perfusion Preservation for Split?Liver Transplantation in Recovering Graft Function and Reducing Ischemia–Reperfusion Injury

Read More
Screening for Mitochondrial Function Before Use-Routine Liver Assessment During Hypothermic Oxygenated Perfusion Impacts Liver Utilization

Screening for Mitochondrial Function Before Use-Routine Liver Assessment During Hypothermic Oxygenated Perfusion Impacts Liver Utilization

Analysis of 415 DCD Maastricht III livers over an 11-year period in Switzerland showed that 249 were transplanted, with 158 performed at the study institution. One-year patient survival and [...]

Read More
Machine Perfusion as “Comfort Zone”: What Are Key Challenges of Liver Viability Assessment Today?

Machine Perfusion as “Comfort Zone”: What Are Key Challenges of Liver Viability Assessment Today?

A review of 203 human livers perfused with NMP, including 154 transplants, revealed that despite well-established viability criteria, 11% of transplanted livers still developed non-anastomotic [...]

Read More
Hypothermic oxygenated perfusion protects from mitochondrial injury before liver transplantation

Hypothermic oxygenated perfusion protects from mitochondrial injury before liver transplantation

This article investigates the role of Hypothermic Oxygenated Machine Perfusion (HOPE) in preventing mitochondrial injury and optimizing liver function before transplantation. The study compares [...]

Read More
Beneficial effects of end-ischemic oxygenated machine perfusion preservation for split-liver transplantation in recovering graft function and reducing ischemia–reperfusion injury

Beneficial effects of end-ischemic oxygenated machine perfusion preservation for split-liver transplantation in recovering graft function and reducing ischemia–reperfusion injury

This study investigates the impact of end-ischemic Hypothermic Oxygenated Machine Perfusion (HOPE) on split-liver transplantation using a porcine model. The research highlights how HOPE helps [...]

Read More
Impact of Machine Perfusion on the Immune Response After Liver Transplantation – A Primary Treatment or Just a Delivery Tool

Impact of Machine Perfusion on the Immune Response After Liver Transplantation – A Primary Treatment or Just a Delivery Tool

This article reviews the role of Machine Perfusion, particularly HOPE in modulating the immune response following liver transplantation. The study examines how ischemia-reperfusion injury (IRI) [...]

Read More
Improved outcomes after hypothermic oxygenated machine perfusion in liver transplantation-Long-term follow-up of a multicenter randomized controlled trial

Improved outcomes after hypothermic oxygenated machine perfusion in liver transplantation-Long-term follow-up of a multicenter randomized controlled trial

This multicenter randomized controlled trial assessed the long-term outcomes of hypothermic oxygenated machine perfusion (HOPE) in liver transplantation using extended criteria donor (ECD) [...]

Read More
Protective mechanisms and current clinical evidence of hypothermic oxygenated machine perfusion (HOPE) in preventing post-transplant cholangiopathy

Protective mechanisms and current clinical evidence of hypothermic oxygenated machine perfusion (HOPE) in preventing post-transplant cholangiopathy

This article explores the protective mechanisms and current clinical evidence of Hypothermic Oxygenated Machine Perfusion (HOPE) in preventing post-transplant cholangiopathy, particularly in [...]

Read More

Latest Posts

UK NICE Issues Guidance Recommending Routine NHS Funding for Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion System

UK NICE Issues Guidance Recommending Routine NHS Funding for Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion System

August 27, 2026

DULUTH, GA, & LONDON, UK - August 27, 2026 - Bridge to Life™ Ltd., a global leader in organ preservation solutions and perfusion technologies, today highlighted the recent release of […]

Read more
Bridge to Life Raises $110 Million to Make Hypothermic Oxygenated Perfusion the Standard of Care in Liver Transplantation and Beyond

Bridge to Life Raises $110 Million to Make Hypothermic Oxygenated Perfusion the Standard of Care in Liver Transplantation and Beyond

August 12, 2026

Financing will further accelerate the already successful early commercial rollout of VitaSmart™ HOPE System Company also advancing an active organ viability assessment tool designed to raise industry standards with a […]

Read more
New Investigator Initiated Research Data Demonstrate Efficacy and Safety of the Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System in Multiple Organ Transplants

New Investigator Initiated Research Data Demonstrate Efficacy and Safety of the Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System in Multiple Organ Transplants

June 23, 2026

Studies in human uterus and small intestine transplants, including head-to-head comparison with normothermic oxygenated perfusion, presented at 2026 Annual Meeting of the American Transplant Congress (ATC) in Boston Duluth, GA […]

Read more




full

info@b2ll.com

US Operations:
3300 Breckinridge Blvd. Suite 200 | Duluth, GA 30096 USA

© 2026 Bridge to Life™ Ltd. All rights reserved.

EVENTS



Sep


15


September 15 – September 16


National Critical Issues Forum



Sep


16


September 16 – September 17


XIII International Course on HPB surgery



Sep


16


September 16 – September 18


SFPC


View Calendar


EXPLORE BTL

Products

Contact & Support

About

Recent News

Privacy Policy

Social Responsibility

Certifications

JOIN OUR EMAIL LIST

SOCIAL MEDIA

Linkedin

X

VitaSmart™ is available in Europe, Saudi Arabia, India, and in all countries accepting the CE mark. VitaSmart™ Hypothermic Oxygenated Perfusion System is authorized to be sold in the US market, pending regulatory approval in all other countries.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search